Company / AR per Share
Dianthus Therapeutics, Inc. /DE/ AR per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.00
FY2025
5-year range
$0.00 / $5.38
FY2022-FY2025
Trend
-96.9%
vs FY2024
Sector context
#112 of 115
Health Care
What the data says
Among 115 Health Care companies, Dianthus Therapeutics, Inc. /DE/ is in the bottom 3% for ar per share. AR per Share has declined for 3 consecutive years, from $5.38 in FY2022 to $0.00 in FY2025.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of -93.2%.
Declined from $0.06 to $0.00 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -93.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 115This company $0.00 Sector average $27.05
▼
-100.0% below sector average
Key checks
Key Insights
- Dianthus Therapeutics, Inc. /DE/'s ar per share has declined for 3 consecutive years.
- In FY2025, ar per share decreased 96.9% year-over-year.
- Ranks #112 out of 115 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -96.9% |
| FY2024 | $0.05 | -4.5% |
| FY2023 | $0.06 | -98.9% |
| FY2022 | $5.38 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026